Leukoblok 4 mg and 5 mg, 10 mg FC Tablets, Chewable Tablets
PDF Leaflet Revision Date: 17 August 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma.
Dosage (summary)
4 mg for children 2-5 years, 5 mg for children 6-14 years, 10 mg for adults and children 15+ years, taken once daily in the evening.
Onset of Action / Duration
Onset: 1 day, Duration: Not specified
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy and lactation; safety not established.
Key Drug Interactions
- CYP inducers (e.g., phenytoin, phenobarbital)
- Gemfibrozil
- Warfarin
Contraindications
- Hypersensitivity to montelukast
- Children under 2 years
Common side effects
- Headache
- Abdominal pain
- Thirst
- Upper respiratory infection
Counselling Points
- Take in the evening
- Do not stop other asthma medications without consulting a doctor
- Report any mood changes or unusual symptoms
Serious warnings
- Not for acute asthma attacks
- Risk of Churg-Strauss syndrome
- Neuropsychiatric events
Important Disclaimer
The Leukoblok 4 mg and 5 mg, 10 mg FC Tablets, Chewable Tablets professional information leaflet below is the property of Smart Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
